论文部分内容阅读
目的:分析目前寮步镇社区高血压患者降脂治疗的现状。方法:从本服务中心慢性病管理系统中导出并纳入系统管理的高血压患者共10314例,了解上述患者降脂治疗的现状,并对该现状进行分析。结果:本组患者的性别、年龄、文化程度以及职业等一般资料存在一定的差异;10314例患者均进行降压治疗,其中进行降脂治疗的患者仅有22.3%,从降脂治疗的患者在不同的性别、年龄、文化程度以及职业的分布来看,不同的性别对于降脂治疗的影响差异无统计学意义(P>0.05);年龄是影响降脂治疗的因素:年龄偏低(<50岁)及年龄偏大(≥80岁)对于降脂治疗的依从性都偏低;从病种分类看,糖尿病合并高血压的降脂治疗比例稍高于单纯高血压患者。结论:在对寮步镇的10314例高血压患者的随访结果发现,降血脂作为综合性干预高血压的重要手段,并未得到足够的重视,在本次调查的10314例患者中,存在未进行降脂治疗或降脂治疗不足等问题。建议提高高血压患者降脂治疗的意识,加大对社区全科医生降脂治疗培训,提高社区全科医生慢性病随访水平。对糖尿病合并高血压的高危患者,应将降脂治疗与降压降糖治疗同步,以更好控制高血压的持续发展以及防控其严重并发症发生。
Objective: To analyze the current status of lipid-lowering therapy in community-based hypertensive patients in Liaobu town. Methods: A total of 10314 cases of hypertensive patients were derived from the chronic disease management system of our service center and included in the system management. The status of lipid-lowering therapy in these patients was analyzed and analyzed. Results: The data of gender, age, education level and occupation were different in this group of patients. Among 10314 patients, antihypertensive treatment was given only in 22.3% There were no significant differences in the effects of different sexes on lipid-lowering therapy among different sexes, ages, educational levels and occupational distributions (P> 0.05). Age was the factor influencing lipid-lowering treatment: the age was lower (<50 Year-old) and older (≥80 years old) for lipid-lowering treatment compliance are low; from the disease classification, the proportion of patients with diabetes mellitus hypertension lipid-lowering therapy slightly higher than the simple hypertensive patients. CONCLUSIONS: Follow-up of 10314 hypertensive patients in Liaobu Town found that lipid lowering as an important means of comprehensive intervention in hypertension has not been given sufficient attention. Of the 10,314 patients in this survey, Lipid-lowering treatment or lipid-lowering treatment and other issues. Proposed to raise the awareness of lipid-lowering therapy in hypertensive patients, increase the GP general practitioners lipid-lowering treatment training, improve community level chronic disease follow-up. High-risk patients with diabetes mellitus and hypertension should be lipid-lowering therapy and antihypertensive treatment should be synchronized to better control the sustained development of hypertension and prevent its serious complications.